Skip to main content

Henrietta Lacks’s Family Seeks Compensation

Family members of Lacks, the donor behind the widely used HeLa cell line, are planning to sue Johns Hopkins University.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

WIKIMEDIA, EMWSeveral family members of Henrietta Lacks, the unwitting donor of tumor cells developed into the widely used HeLa cell line, say they were never compensated for the cells. They are now planning to sue Johns Hopkins University, which developed the cell line without Lacks’s permission several decades ago, according to The Baltimore Sun.

“Everyone else is making funds off of Henrietta’s cells,” Lacks’s grandson, Ron Lacks, told the Sun. “I am sure my grandmother is up in heaven saying, ‘Well, what about my family?’”

Johns Hopkins told the newspaper that the institution had never patented nor profited from the cells.

The Lacks story was documented in a book, The Immortal Life of Henrietta Lacks, which highlighted how the paucity of informed consent affected her family. In 2013, family members worked out a deal with the National Institutes of Health for the appropriate sharing of the HeLa genome with researchers. At the time, journalist Rebecca Skloot, who wrote The Immortal Life, told The Scientist that commercialization was discussed during negotiations between the Lackses and the NIH, but that science ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo